Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity - PubMed (original) (raw)
Affiliations
- PMID: 11805008
Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity
Dick C Chan et al. Clin Chem. 2002 Feb.
Abstract
Background: Triglyceride-rich lipoprotein remnants are atherogenic, and this may be particularly important in visceral obesity. We investigated remnant metabolism in obese men by measuring remnant-like particle-cholesterol (RLP-C), apolipoprotein (apo) B-48, apoC-III, and the clearance of a labeled remnant-like emulsion.
Methods: Fasting RLP-C, apoB-48, and apoC-III concentrations were measured in 48 viscerally obese men and 10 lean controls. RLP-C was determined by immunoseparation assay, apoB-48 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and enhanced chemiluminescence, and apoC-III by immunoturbidimetric assay. The catabolism of chylomicron remnants was measured by intravenous injection of a remnant-like emulsion containing cholesteryl [(13)C]oleate, with isotopic enrichment of (13)CO(2) in breath determined by isotope-ratio mass spectrometry and a multicompartmental model to estimate fractional catabolic rate (FCR) of the emulsion.
Results: Compared with controls, obese men had significantly increased plasma concentrations of RLP-C, apoB-48, and apoC-III (P <0.001 for all). Plasma total apoB-100, non-HDL-cholesterol, LDL-cholesterol, triglycerides, and insulin resistance (HOMA score) were also significantly higher in the obese group (P <0.001 for all). Obese men had a significantly lower FCR of the remnant-like emulsion compared with controls (P = 0.020).
Conclusions: Viscerally obese individuals have insulin resistance and increased plasma concentrations of triglyceride-rich lipoprotein remnants, which may be attributable to decreased catabolism of these particles.
Comment in
- Remnant lipoproteins: measurement and clinical significance.
Jialal I, Devaraj S. Jialal I, et al. Clin Chem. 2002 Feb;48(2):217-9. Clin Chem. 2002. PMID: 11805002 No abstract available.
Similar articles
- Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia.
Dane-Stewart CA, Watts GF, Mamo JC, Barrett PH, Martins IJ, Dimmitt SB, Redgrave TG. Dane-Stewart CA, et al. Eur J Clin Invest. 2002 Jul;32(7):493-9. doi: 10.1046/j.1365-2362.2002.01012.x. Eur J Clin Invest. 2002. PMID: 12153549 Clinical Trial. - Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism.
Chan DC, Watts GF, Ng TW, Uchida Y, Sakai N, Yamashita S, Barrett PH. Chan DC, et al. Clin Chem. 2005 Mar;51(3):578-85. doi: 10.1373/clinchem.2004.045120. Epub 2005 Jan 13. Clin Chem. 2005. PMID: 15650029 - Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
Chan DC, Watts GF, Redgrave TG, Mori TA, Barrett PH. Chan DC, et al. Metabolism. 2002 Aug;51(8):1041-6. doi: 10.1053/meta.2002.33339. Metabolism. 2002. PMID: 12145779 - Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins.
Cohn JS, Marcoux C, Davignon J. Cohn JS, et al. Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2474-86. doi: 10.1161/01.atv.19.10.2474. Arterioscler Thromb Vasc Biol. 1999. PMID: 10521378 Review. - Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
Sniderman A, Couture P, de Graaf J. Sniderman A, et al. Nat Rev Endocrinol. 2010 Jun;6(6):335-46. doi: 10.1038/nrendo.2010.50. Epub 2010 Apr 27. Nat Rev Endocrinol. 2010. PMID: 20421882 Review.
Cited by
- Relationship of serum lipid parameters with kidney function decline accompanied by systemic arterial stiffness: a retrospective cohort study.
Nagayama D, Watanabe Y, Yamaguchi T, Fujishiro K, Suzuki K, Shirai K, Saiki A. Nagayama D, et al. Clin Kidney J. 2023 May 26;16(11):2289-2298. doi: 10.1093/ckj/sfad131. eCollection 2023 Nov. Clin Kidney J. 2023. PMID: 37915913 Free PMC article. - Anti-atherogenic and cardio-protective properties of sweet melon (Cucumis melo. L. Inodorus) seed extract on high fat diet induced obesity in male wistar rats.
Adebayo-Gege G, Alicha V, Omayone TO, Nzekwe SC, Irozuoke CA, Ojo OA, Ajayi AF. Adebayo-Gege G, et al. BMC Complement Med Ther. 2022 Dec 20;22(1):334. doi: 10.1186/s12906-022-03793-w. BMC Complement Med Ther. 2022. PMID: 36539762 Free PMC article. - Intestinal lipid absorption and transport in type 2 diabetes.
Vergès B. Vergès B. Diabetologia. 2022 Oct;65(10):1587-1600. doi: 10.1007/s00125-022-05765-8. Epub 2022 Jul 30. Diabetologia. 2022. PMID: 35908083 Review. - Postprandial dyslipidemia in insulin resistant states in adolescent populations.
Higgins V, Adeli K. Higgins V, et al. J Biomed Res. 2020 Jan 30;34(5):328-342. doi: 10.7555/JBR.34.20190094. J Biomed Res. 2020. PMID: 32934193 Free PMC article. - The Complex Interactions Between Obesity, Metabolism and the Brain.
Uranga RM, Keller JN. Uranga RM, et al. Front Neurosci. 2019 May 24;13:513. doi: 10.3389/fnins.2019.00513. eCollection 2019. Front Neurosci. 2019. PMID: 31178685 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous